No abstract available
Keywords:
biomarker; cancer; immune infiltration; immune system; multi-omics; proteomics; transcriptomics.
Grants and funding
This Editorial was supported by the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme with an ERC Advanced Grant (ERC-2015-AdG 695655, TiMaScan). PD and CJ are the recipients of a Sara Borrell postdoctoral fellowship (Institute of Health Carlos III, Spanish Government; CD19/00030 for CJ, CD22/00009 for PD).